Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 7/20 | 0.47 |
| ▸ | WNT3A | P56704 | 1/20 | 0.40 |
| ▸ | JAK2 | O60674 | 5/20 | 0.40 |
| ▸ | JAK3 | P52333 | 5/20 | 0.40 |
| ▸ | PTK2 | Q05397 | 5/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 3/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.36 |
| ▸ | RET | P07949 | 1/20 | 0.36 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.35 |
| ▸ | MASP2 | O00187 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31744286 | 0.86 | JAK3 (0.39) | NAMPTJAK3MASP2 | |
| SCHEMBL15376674 | 0.86 | NAMPT (0.53) | NAMPTWNT3AJAK2JAK3PTK2 | |
| SCHEMBL31744299 | 0.83 | NAMPT (0.38) | NAMPTWNT3ARET | |
| SCHEMBL15376951 | 0.81 | NAMPT (0.50) | NAMPTWNT3AKEAP1NFE2L2USP30 | |
| SCHEMBL31744290 | 0.81 | NAMPT (0.45) | NAMPT | |
| SCHEMBL15376073 | 0.78 | NAMPT (0.46) | NAMPTMASP2 | |
| SCHEMBL31037472 | 0.78 | NAMPT (0.47) | NAMPTWNT3AJAK2JAK3PTK2 | |
| SCHEMBL15376266 | 0.77 | NAMPT (0.51) | NAMPT | |
| SCHEMBL15377846 | 0.77 | NAMPT (0.46) | NAMPTWNT3AJAK3 | |
| SCHEMBL31037312 | 0.76 | GPR119 (0.45) | NAMPTWNT3AJAK2JAK3PTK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4663628-A1 | NEW COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Samjin Pharmaceutical Co., Ltd. (KR) | 2025-12-17 | — | — | EP | disclosed |